A request arrives with eighty pages of records. The question is whether to authorize one service at one setting for a particular patient. Reading everything without identifying that question can leave you informed about the chart and still unable to make the decision.
What decision is yours?
Utilization review assesses a request or episode within an assigned framework. Before reaching a conclusion, identify the patient, plan and product, requested service and setting, relevant dates, urgency, and your authority. Some physicians recommend an outcome to an organization; others can issue specified determinations. Know which role you hold and when another specialty or level of review is required.
| Issue | Question to answer |
|---|---|
| Medical necessity | Does the evidence support this service for this patient's circumstances under the applicable standard? |
| Benefit coverage | Does this product include the service, and what restrictions or exceptions apply? |
| Setting or network | Is the requested site covered and appropriate, and is the proposed alternative actually capable and accessible? |
| Prospective authorization | What must be decided before care occurs, and how soon does the patient's health require a response? |
| Retrospective payment dispute | What happened during the completed episode, and what part of payment is disputed? |
A benefit exclusion and a finding of medical necessity are different conclusions. So are a network mismatch and inadequate clinical evidence. State the actual issue. The treating clinician remains responsible for treatment; the reviewer must communicate the coverage decision without pretending it resolves every clinical or access problem.
CMS organization determinations describes the scope of Medicare health-plan decisions. For the ordering office's perspective, see Coverage and Reimbursement.
Match evidence to the right policy
Find the governing benefit and coverage framework before opening a screening tool. Record the policy version and effective date relevant to the request. A familiar checklist may concern another product, procedure, or date. Its failure to match the case is a reason to investigate applicability, not proof that care is inappropriate.
For Medicare Advantage basic benefits, applicable Medicare coverage requirements matter. Internal coverage criteria are permitted only under specified conditions when Medicare criteria are not fully established, and the patient's individual circumstances must be considered. A tool or algorithm cannot substitute for that assessment.
CMS coverage and utilization-management FAQ; 42 CFR 422.101. Do not import the fictional commercial rules below into this Medicare framework.
Organize the record around the decision: the condition and course, objective findings, relevant treatment and response, functional effect, and the proposed service's purpose. Preserve discordant evidence. A record can be incomplete, a criterion can be unmet, or an exception can apply; those are three different situations.
Missing records, then an approval
The omitted therapy dates
Fictional Harbor Commercial Plan, policy P-17, effective January 1, 2026. For this teaching case only, the nonurgent lumbar MRI pathway requires persistent radicular symptoms limiting function after at least six weeks of documented clinician-directed nonoperative care, with imaging intended to inform an intervention decision. Its exceptions include an urgent clinical indication or a documented reason the usual pathway cannot appropriately be used.
The submitted note says “pain despite therapy,” without dates. Before deciding, the reviewer confirms that P-17 applies to this fictional product and request and asks for the treatment interval, response, relevant assessment, and intended next decision. The question is whether the supporting facts are absent from the packet or absent from the patient's care.
“Please send the assessment and treatment records showing when clinician-directed care began, what was tried, and the response. The current note does not give those dates. Also identify any new neurologic findings or reason the usual pathway is inappropriate; those could change the urgency and review.”
| P-17 question | Additional records establish | Interpretation |
|---|---|---|
| Adequate documented treatment interval? | Clinician-directed home exercise July 1–August 20; six therapy visits July 8–August 19. | The fictional six-week interval is established. |
| Persistent functional limitation? | August 20 assessment describes continuing radicular pain limiting walking to ten minutes. | The required limitation remains despite the documented trial. |
| A decision the study will inform? | The spine specialist plans to assess a matching structural lesion before deciding on an intervention. | The request has a stated management purpose. |
Approval rationale: The additional July 1–August 20 records establish the treatment interval and persistent walking limitation required by Harbor P-17. The specialist's documented next decision explains the requested MRI. Approve the requested lumbar study within the reviewer's delegated authority; the authorization team will issue the service, site, validity, and notification details required by this plan.
A new urgent finding would require direct communication with the treating team and appropriate expedited handling. It should not wait inside a routine records exchange. The invented six-week criterion is not a clinical recommendation for all back pain.
Keep requests precise and proportionate. Asking for the entire chart again when one dated note would resolve the gap adds work for the treating office and delay for the patient. Track what was requested, when it is due under the applicable process, and who will act when it arrives. A missing record does not justify indefinite deferral.
A useful peer discussion
Prepare one sentence describing the uncertainty. Read the available evidence before asking the treating physician to repeat it. Confirm that the person on the call has the information and that you have the expertise and authority needed to act—or a defined route to someone who does.
The alternative site cannot provide the required monitoring
Fictional Harbor Commercial Plan, site policy S-4. For this case, a covered infusion ordinarily uses a participating freestanding center. The policy permits a hospital outpatient exception when documented monitoring needs cannot be met at an appropriate participating alternative within the required clinical timeframe.
A prior infusion reaction led the treating specialist to prescribe a specific post-infusion monitoring period. A specialty reviewer confirms the documented need. The proposed freestanding center cannot staff that period for its available appointment. The hospital day unit can. These are case facts, not a monitoring protocol for an unnamed drug.
Reviewer: “The service itself is covered. I need to resolve whether the proposed center can meet the documented monitoring plan. What capability is missing?”
Treating physician: “Its intake team confirmed that staff would leave before the monitoring period ends. The reaction record and plan are in the packet.”
Reviewer: “I have reviewed those records with the specialist reviewer. We will verify the center's limitation and whether another suitable appointment exists within the needed timeframe. If none does, the stated exception addresses this request.”
The plan confirms that no appropriate participating alternative is available within that timeframe. The reviewer approves the hospital setting under S-4 and documents the specific exception. However, the hospital still has to confirm its appointment. Authorization staff accept responsibility for arranging that contact and updating the treating team by 15:00 on September 5, before the planned September 8 treatment. These dates are specific to the fictional case; failure to secure the appointment returns to the reviewer and treating team for timely reassessment. The conversation resolved coverage; the patient's access task remains open.
A conversation can also end without agreement. Record the disputed criterion, the additional facts supplied, and the next authorized review step. Avoid promising an outcome beyond your authority or implying that a peer call has automatically replaced a formal appeal.
A supported adverse decision
Severe symptoms, a shorter trial, and a real disagreement
Separate fictional patient under Harbor Commercial Plan P-17. The patient has two weeks of radicular pain substantially affecting work. The treating physician wants an earlier answer to decide whether to pursue a targeted intervention and requests MRI before the fictional policy's usual treatment interval is complete. The reviewer accepts that the management-purpose requirement is met; the disputed element is timing and whether an exception applies.
The complete record documents preserved strength, no identified urgent indication, and two weeks of clinician-directed care. The reviewer discusses the functional burden and asks whether a contraindication or other circumstance makes the usual pathway inappropriate. The physician reports difficulty attending therapy appointments, but confirms that the clinician-directed home program is feasible. P-17 accepts that form of care; supervised therapy attendance is not its requirement. The reviewer considers the stated exceptions and finds none established in this record.
Rationale excerpt: This lumbar MRI request is not approved under Harbor P-17 on the current record. The September 5 assessment documents substantial work limitation but only two weeks of clinician-directed care, compared with the six weeks required by the applicable pathway. The record and physician discussion do not establish an urgent indication or a reason that pathway cannot appropriately be used. Limited access to supervised therapy was considered; this policy also accepts the feasible clinician-directed home program described. New clinical findings or evidence supporting an exception should receive further review through the applicable process.
Plain-language explanation: “We recognize that the pain is affecting your work. This plan's usual MRI pathway requires six weeks of clinician-directed treatment; the records show two weeks. We reviewed the reasons for earlier imaging with your physician but did not establish an exception under this policy. The request is not approved on that basis. You still need care, and the notice explains how to challenge this decision. Your treating clinician should reassess any change in your condition.”
This is a rationale example, not a complete adverse-benefit notice. The organization must provide the required reason, rights, deadlines, and other notice content for the actual product. If a new assessment identifies a qualifying exception, review it promptly and explain why the outcome changes. Record which new fact changed the decision.
If the restriction itself is improper or inapplicable, escalate it through the organization’s process. A carefully worded rationale cannot repair the use of the wrong standard.
Decisions, notices, and appeals
Identify the clock before scheduling work. An initial request, the patient's time to file an appeal, and the plan's time to decide that appeal are separate intervals. The decision intervals below run from the plan’s receipt of the respective request. The patient's health may require faster action than the outer limit. Requests for information and peer discussions do not automatically stop or extend a clock.
| Process | Standard | Expedited |
|---|---|---|
| Initial prior-authorization decision | Seven calendar days | 72 hours |
| Pre-service Part C reconsideration decision | 30 calendar days | 72 hours |
For Part C reconsideration, the usual filing period is 65 calendar days from the date of the determination notice. Acceptance of a late appeal and an extension of a decision deadline are separate provisions with their own conditions. Use the actual notice and current rules. Do not apply these selected intervals to every product, drug request, payment dispute, or later appeal stage.
CMS-0057-F prior-authorization requirements; CMS Part C reconsiderations. Permitted extensions require their own conditions; act as quickly as the patient's health requires.
For a retrospective dispute, preserve what was knowable when care was delivered. Later recovery, a later diagnosis, or a subsequently obtained record may matter, but should not be represented as information the treating physician had earlier. Also establish whether the issue is clinical coverage or a correctable claim error before launching a medical argument.
Doing this work responsibly
Review work has consequences beyond the determination. Repeated submissions use treating-team time, unclear notices leave patients unsure what to do, and an unreachable reviewer can turn a small information gap into a care delay. When several cases fail for the same reason, examine the intake process rather than sending the same request indefinitely.
For example, if the portal collects a generic therapy checkbox but never its dates or outcome, bring that defect to the process owner with several de-identified examples. Propose capturing the decisive information once and check whether repeat requests decrease. Changing an intake field requires organizational authority, but identifying the recurring failure is part of thoughtful review.
Before accepting a reviewer job, ask for a sample case and its escalation history. Who can disagree with your decision, who can overrule it, and where is the reasoning recorded? How are specialty consultation, difficult cases, protected records, and final notices handled? What happens when the assigned volume does not permit an adequate review? These answers reveal more than a title or a promised number of cases per hour.
Use approved systems for patient records. If tools assist with summaries or policy retrieval, verify the source material and remain accountable for the determination. A missing sentence in a summary is not evidence that a finding is absent from the chart. The work should leave an understandable trail from the request and applicable rule to the facts, judgment, and next step.